Back to Journals » International Journal of Nanomedicine » Volume 7

5-aminolevulinic acid-incorporated poly(vinyl alcohol) nanofiber-coated metal stent for application in photodynamic therapy

Authors Yoo, Kim, Chung C, Jeong Y, Kang DH

Received 28 January 2012

Accepted for publication 12 March 2012

Published 3 May 2012 Volume 2012:7 Pages 1997—2005


Review by Single-blind

Peer reviewer comments 3

Jin Ju Yoo*, Chan Kim*, Chung-Wook Chung, Young-Il Jeong, Dae Hwan Kang
National Research and Development Center for Hepatibiliary Disease, Pusan National University Yangsan Hospital, Gyeongnam 626-770, Korea

*These authors contributed equally to this work.

Background: The study investigated the use of combined photodynamic therapy (PDT) and stent placement for the treatment of cholangiocarcinoma (CC). For this purpose, 5-aminolevulinic acid (ALA) was incorporated into poly(vinyl alcohol) (PVA) nanofiber, and coated onto metal stents. Their efficacy was assessed in PDT towards HuCC-T1 CC cells.
Methods: Fabrication of ALA-PVA nanofiber, and simultaneous coating onto metal stents, was performed through electrospinning. The dark-toxicity, generation of protoporphyrin IX (PpIX), and PDT effect of ALA and ALA-PVA nanofiber were studied in vitro, using HuCC-T1 CC cells.
Results: The ALA-PVA nanofibers were coated onto metal stents less than 1000 nm in diameter. ALA-only displayed marginal cytotoxicity; ALA-PVA nanofiber showed less cytotoxicity. PpIX generation was not sigficantly different between ALA and ALA-PVA nanofiber treatments. PVA itself did not generate PpIX in tumor cells. ALA and ALA-PVA nanofiber displayed a similar PDT effect on tumor cells. Cell viability was decreased, dose-dependently, until ALA concentration reached 100 µg/mL. Necrosis and apoptosis of tumor cells occurred similarly for ALA and ALA- PVA nanofiber treatments.
Conclusion: The ALA-PVA nanofiber-coated stent is a promising candidate for therapeutic use with cholangiocarcinoma.

Keywords: nanofiber, photodynamic therapy, 5-aminolevulinic acid, poly(vinyl alcohol)

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]


Other articles by this author:

Vorinostat-eluting poly(DL-lactide-co-glycolide) nanofiber-coated stent for inhibition of cholangiocarcinoma cells

Kwak TW, Lee HL, Song YH, Kim C, Kim JS, Seo SJ, Jeong YI, Kang DH

International Journal of Nanomedicine 2017, 12:7669-7680

Published Date: 17 October 2017

Anticancer activities of epigallocatechin-3-gallate against cholangiocarcinoma cells

Kwak TW, Park SB, Kim HJ, Jeong YI, Kang DH

OncoTargets and Therapy 2017, 10:137-144

Published Date: 22 December 2016

Enzyme-responsive doxorubicin release from dendrimer nanoparticles for anticancer drug delivery

Lee SJ, Jeong YI, Park HK, Kang DH, Oh JS, Lee SG, Lee HC

International Journal of Nanomedicine 2015, 10:5489-5503

Published Date: 28 August 2015

Release of tissue inhibitor of metalloproteinase-2 from alginate microcapsule encapsulating genetically engineered cells

Kim YS, Jeong YI, Jin SG, Pei J, Wen M, Kim IY, Moon KS, Jung TY, Ryu HH, Jung S

International Journal of Nanomedicine 2013, 8:4351-4359

Published Date: 6 November 2013

Dextran-b-poly(L-histidine) copolymer nanoparticles for pH-responsive drug delivery to tumor cells

Hwang JH, Choi CW, Kim HW, Kim DH, Kwak TW, Lee HM, Kim CH, Chung CW, Jeong YI, Kang DH

International Journal of Nanomedicine 2013, 8:3197-3207

Published Date: 21 August 2013

Doxorubicin-incorporated polymeric micelles composed of dextran-b-poly(DL-lactide-co-glycolide) copolymer

Jeong YI, Kim DH, Chung CW, Yoo JJ, Choi KH, Kim CH, Ha SH, Kang DH

International Journal of Nanomedicine 2011, 6:1415-1427

Published Date: 6 July 2011

Readers of this article also read:

Activation of mTOR: a culprit of Alzheimer’s disease?

Cai Z, Chen G, He W, Xiao M, Yan LJ

Neuropsychiatric Disease and Treatment 2015, 11:1015-1030

Published Date: 9 April 2015

Antimicrobial activity of metal oxide nanoparticles against Gram-positive and Gram-negative bacteria: a comparative study

Azam A, Ahmed AS, Oves M, Khan MS, Habib SS, Memic A

International Journal of Nanomedicine 2012, 7:6003-6009

Published Date: 5 December 2012

pH-sensitive strontium carbonate nanoparticles as new anticancer vehicles for controlled etoposide release

Qian WY, Sun DM, Zhu RR, Du XL, Liu H, Wang SL

International Journal of Nanomedicine 2012, 7:5781-5792

Published Date: 20 November 2012


Iancu C, Mocan L

International Journal of Nanomedicine 2011, 6:2543-2544

Published Date: 21 October 2011

Nanotoxicology and nanoparticle safety in biomedical designs

Ai J, Biazar E, Jafarpour M, Montazeri M, Majdi A, Aminifard S, Zafari M, Akbari HR, Rad HG

International Journal of Nanomedicine 2011, 6:1117-1127

Published Date: 31 May 2011

Erratum - Intracellular heavy metal nanoparticle storage

Iannitti T, Capone S, Gatti A, et al

International Journal of Nanomedicine 2011, 6:239-240

Published Date: 26 January 2011

Stability and antimicrobial effect of amikacin-loaded solid lipid nanoparticles

Solmaz Ghaffari, Jaleh Varshosaz, Afrooz Saadat, et al

International Journal of Nanomedicine 2011, 6:35-43

Published Date: 16 December 2010